Glucocorticoids (GCs) are steroids with profound anti-inflammatory and immunomodulatory
activities. Synthetic GCs are widely used for managing chronic inflammatory and …

Multiple myeloma (MM), an incurable hematologic malignancy of plasma cells increasing in
the bone marrow (BM), has a complex microenvironment made to support proliferation …

Since the 1950s, glucocorticoids (GCs) have been a mainstay therapy for acute and chronic
inflammatory disorders, although adverse effects limit their chronic use. Following the notion …

Glucocorticoids are essential drugs in the treatment protocols of lymphoid malignancies.
These steroidal hormones trigger apoptosis of the malignant cells by binding to the …

Myasthenia gravis (MG) is an autoimmune disease caused by antibodies which attack
receptors at the neuromuscular junction. One of the main difficulties in predicting the clinical …

Toll-like receptor (TLR)-mediated innate immune responses are critically involved in the
pathogenesis of myasthenia gravis (MG), an autoimmune disorder affecting neuromuscular …

Simple Summary Multiple myeloma (MM) is the second most common haematologic
malignancy, and it remains an incurable disease despite the advances of novel therapies. It …

Hematological malignancies (HM) represent a subset of neoplasms affecting the blood,
bone marrow, and lymphatic systems, categorized primarily into leukemia, lymphoma, and …

Glucocorticoids have been widely used in the treatment of ulcerative colitis, but not all
patients benefit from this therapy due to hormone resistance. Mir-150–5p has been reported …

Background: Long noncoding RNA (lncRNA)-PRLB (progression-associated lncRNA in
breast cancer) has been identified to enhance the drug resistance of breast cancer cells. In …